India, Aug. 29 -- iBio Inc. (IBIO), a clinical-stage biotechnology company, released on Friday financial results for the fiscal year ending June 30, 2026, noting a wider net loss as expenses related t... Read More
India, Aug. 29 -- Calvin Klein, Inc. has unveiled the first chapter of its Fall 2026 "Feel the Fit" denim campaign starring Grammy Award-nominated pop sensation Tate McRae. Rolling out over the next ... Read More
India, Aug. 28 -- Aprea Therapeutics, Inc. (APRE), a clinical-stage precision medicine oncology company focused on targeted therapies for biomarker-defined cancers, announced an expansion of its globa... Read More
India, Aug. 28 -- Federal Reserve Chairman Kevin Warsh delivered his highly anticipated debut speech as the head of the central bank at the Jackson Hole economic symposium on Friday. As widely expect... Read More
India, Aug. 28 -- A new way of supporting people during a mental health crisis could reduce hospital admissions and improve their experience of care, according to a study led by a researcher at Univer... Read More
India, Aug. 28 -- The U.S. Food and Drug Administration approved Takeda Pharmaceutical's (TAK,TKPHF,4502.T) Mimrylo (rusfertide), a new treatment for adults with polycythemia vera, a rare blood disord... Read More
India, Aug. 28 -- It has been a year of meaningful execution for Candel Therapeutics Inc. (CADL), marked by important clinical milestones, regulatory progress, and growing momentum across its pipeline... Read More
India, Aug. 28 -- Affirm Holdings, Inc. (AFRM) shares rose 6.83 percent to $82.78 on Friday, possibly following the company's strong fourth-quarter results reported the previous day. The stock opened... Read More
India, Aug. 28 -- Shares of Moderna, Inc. (MRNA) are falling around 6 percent on Friday morning after the company announced pricing of a $2.6 billion private offering of Convertible Senior Notes due 2... Read More
India, Aug. 28 -- BioNTech SE (BNTX), a biotechnology company focused on developing individualized cancer immunotherapies, announced the termination of its Phase 2 BNT122-01 trial evaluating autogene ... Read More